Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ESMO open

Showing results (91-100 of 2,246) with videos related to

Pageof 225
Sort By:
ESMO Open|August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world studyM Nannini, A Rizzo, M C Nigro, et al.
ESMO Open|August 13, 2021
Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive reviewI Solares, D Viñal, M Morales-Conejo, et al.
ESMO Open|December 1, 2016
Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colorectal cancer: the ACCORE studyC M Lund, D Nielsen, C Dehlendorff, et al.
ESMO Open|December 1, 2016
ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answersN I Cherny, R Sullivan, U Dafni, et al.
ESMO Open|December 1, 2016
In the literature: October 2016Andres Cervantes
ESMO Open|December 10, 2016
Molecular pathology of cancer: how to communicate with diseasePeter Birner, Gerald Prager, Berthold Streubel
ESMO Open|December 10, 2016
Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016Han van Krieken, Sandi Deans, Jacqueline A Hall, et al.
ESMO Open|March 4, 2017
Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)Massimo Di Maio, Paolo Bruzzi, Francesco Perrone, et al.
ESMO Open|December 10, 2016
CSCO joins ESMO Open-Cancer HorizonsChristoph C Zielinski, Yi-Long Wu
ESMO Open|November 16, 2016
A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosisD Jenni, M B Karpova, B Mühleisen, et al.
Pageof 225

Showing results (91-100 of 2,246) with videos related to

Sort By:
Pageof 225
ESMO Open|August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world studyM Nannini, A Rizzo, M C Nigro, et al.
ESMO Open|August 13, 2021
Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive reviewI Solares, D Viñal, M Morales-Conejo, et al.
ESMO Open|December 1, 2016
Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colorectal cancer: the ACCORE studyC M Lund, D Nielsen, C Dehlendorff, et al.
ESMO Open|December 1, 2016
ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answersN I Cherny, R Sullivan, U Dafni, et al.
ESMO Open|December 1, 2016
In the literature: October 2016Andres Cervantes
ESMO Open|December 10, 2016
Molecular pathology of cancer: how to communicate with diseasePeter Birner, Gerald Prager, Berthold Streubel
ESMO Open|December 10, 2016
Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016Han van Krieken, Sandi Deans, Jacqueline A Hall, et al.
ESMO Open|March 4, 2017
Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)Massimo Di Maio, Paolo Bruzzi, Francesco Perrone, et al.
ESMO Open|December 10, 2016
CSCO joins ESMO Open-Cancer HorizonsChristoph C Zielinski, Yi-Long Wu
ESMO Open|November 16, 2016
A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosisD Jenni, M B Karpova, B Mühleisen, et al.
Pageof 225